Financial giants have made a conspicuous bullish move on Boston Scientific. Our analysis of options history for Boston Scientific (NYSE:BSX) revealed 21 unusual trades.
Delving into the details, we found 47% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $736,966, and 14 were calls, valued at $1,123,050.
Predicted Price Range
After evaluating the trading volumes and Open Interest, it’s evident that the major market movers are focusing on a price band between $80.0 and $97.0 for Boston Scientific, spanning the last three months.
Analyzing Volume & Open Interest
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Boston Scientific’s options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Boston Scientific’s substantial trades, within a strike price spectrum from $80.0 to $97.0 over the preceding 30 days.
Boston Scientific 30-Day Option Volume & Interest Snapshot
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BSX | CALL | SWEEP | BULLISH | 09/18/26 | $11.0 | $10.4 | $11.0 | $90.00 | $440.2K | 174 | 425 |
| BSX | PUT | SWEEP | BULLISH | 03/20/26 | $2.9 | $2.85 | $2.85 | $90.00 | $228.8K | 7.1K | 690 |
| BSX | CALL | TRADE | BULLISH | 06/17/27 | $14.5 | $14.5 | $14.5 | $92.50 | $145.0K | 6 | 100 |
| BSX | PUT | SWEEP | BEARISH | 02/20/26 | $2.6 | $2.4 | $2.45 | $90.00 | $144.2K | 2.3K | 1.3K |
| BSX | CALL | SWEEP | BULLISH | 09/18/26 | $10.9 | $10.9 | $10.9 | $90.00 | $111.1K | 174 | 507 |
About Boston Scientific
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm’s total sales.
After a thorough review of the options trading surrounding Boston Scientific, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Present Market Standing of Boston Scientific
- Trading volume stands at 6,852,637, with BSX’s price down by 0.0%, positioned at $92.28.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 13 days.
Expert Opinions on Boston Scientific
1 market experts have recently issued ratings for this stock, with a consensus target price of $100.0.
- An analyst from Oppenheimer persists with their Outperform rating on Boston Scientific, maintaining a target price of $100.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements.
Market News and Data brought to you by Benzinga APIs
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.